Nov 16, 2021 / 12:20PM GMT
Brandon Couillard - Jefferies LLC, Research Division - Equity Analyst
Thanks, everybody, for joining us. Man, it feels great to be back in person at the Jefferies London Conference. I'm Brandon Couillard. I cover the life science tools and diagnostics sector here at the firm. Very happy to have Bruker with us back at the conference in person this year. And joining us for this conversation, CFO, Gerald Herman. Thanks for being here.
Gerald N. Herman - Bruker Corporation - Executive VP & CFO
Hello, everyone. Yes, pleasure to be here. Thanks for all of you for being here.
Questions and Answers:
Brandon Couillard - Jefferies LLC, Research Division - Equity AnalystMaybe just to start off the conversation, I think it would be helpful just to sort of level set the year, which has been pretty impressive in terms of you've been putting up successive series of big beats and raises. If we look at where you're kind of expecting organic growth for the year, you're talking kind of 17% at the midpoint, which is double
Trustpilot
